The threat of bioterrorism has prompted the government to invest billions of dollars to defend against such an attack as well as impose new restrictions on how research is conducted. In the Jan. 12 issue of the New England Journal of Medicine, David Relman, MD, associate professor of microbiology and immunology at the Stanford University School of Medicine, has an opinion piece evaluating the threat and the nation’s response. The interview below is adapted from that article, available at http://content.nejm.org/cgi/content/full/354/2/113. Relman is a member of the U.S. Health and Human Services Department’s National Science Advisory Board for Biosecurity.
